A small number of COVID-19 'breakthrough' cases are expected after vaccination, and health officials say they’re not a cause for alarm
It’s when a fully vaccinated person gets infected with the coronavirus. A small number of such cases are expected, and health officials say they’reCOVID-19 vaccines work by teaching the body to recognize the virus. So if you’re exposed to it after vaccination, your immune system should be ready to spring into action and fight it.
Either way, while the vaccines are very good at protecting us from the virus, it’s still possible to get infected and perhaps develop symptoms.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
COVID-19 Cases In U.S. Triple Over 2 Weeks Amid MisinformationCOVID-19 cases have tripled in the U.S. over two weeks amid an onslaught of vaccine misinformation.
Leer más »
Cape Cod COVID-19 cluster grows to more than 130 infected, prompting renewed mitigation effortsOfficials in Provincetown, Massachusetts, issued a number of renewed mitigation measures on Monday after at least 132 individuals tested positive for COVID-19 in the weeks after the holiday weekend.
Leer más »
Why breakthrough COVID-19 infections don't mean the vaccine isn't workingBreakthrough COVID-19 cases aren't proof the vaccines aren't working, experts say, but are normal and expected.
Leer más »
South Korea logs record rise in daily Covid-19 cases - latest updatesSouth Korea logs another record rise in daily Covid-19 cases. Here are other updates: 🇵🇪 Peru arrests hospital workers over bed scam 🇦🇺 Victoria state's cases rise amid lockdowns in Australia 🇺🇸 President Biden urges vaccinations at town hall For more:
Leer más »
J&J raises revenue forecast, estimates $2.5 bln in COVID-19 vaccine salesJohnson & Johnson (JNJ.N) raised its 2021 revenue estimates on Wednesday and forecast it would sell $2.5 billion worth of its COVID-19 vaccine this year, as it strives to quell production and safety problems and catch up with rivals Pfizer and Moderna.
Leer más »